Impact of sputum quality on Xpert MTB/RIF Ultra test results for tuberculosis: A multi-country study

A multi-country study of 1,855 participants demonstrates that sputum quality does not independently affect Xpert MTB/RIF Ultra positivity and that the test maintains high sensitivity and specificity across all sputum grades, supporting the molecular testing of all sputum samples regardless of their macroscopic appearance.

The Gist

Imagine you are trying to find a tiny, invisible needle (the tuberculosis bacteria) hidden inside a massive haystack. For decades, doctors believed that to find this needle, the haystack had to be a specific type: thick, sticky, and yellowish-green (what we call "purulent" or "mucoid" sputum). If the haystack looked like clear, runny water (saliva), they thought it was useless and threw it away, asking the patient to try again.

This study is like a massive, global experiment to see if that old rule still makes sense when we use a super-powerful new metal detector called Xpert Ultra.

Here is the story of what they found, broken down simply:

The Old Rule vs. The New Tool

In the past, when doctors used simple microscopes to look for TB, they needed a thick, gooey sample because the bacteria were often stuck in the mucus. If the sample was just spit, they thought, "There's nothing in here," and rejected it.

But Xpert Ultra is different. It's not just a microscope; it's a high-tech DNA scanner. It's so sensitive it can find the bacteria's genetic code even if there are only a few of them floating around. The big question was: Does this super-scanner still need a thick, gooey sample, or can it find the needle in a watery haystack too?

The Great Global Test

The researchers didn't just test this in one town; they went to seven different countries (including India, Nigeria, South Africa, and Vietnam) and tested 1,855 people.

They collected samples from everyone and graded them like a food critic grading soup:

• The "Gooey" Soup: Thick, yellow, or green (Purulent/Mucoid).
• The "Watery" Soup: Clear, thin, just saliva (Salivary).

They ran the samples through the Xpert Ultra machine and compared the results to the "gold standard" (growing the bacteria in a lab culture).

The Big Surprise

The results were a game-changer:

1. The "Watery" Soup Worked Just as Well: The machine found the TB bacteria in the clear, watery saliva almost as often as it did in the thick, gooey samples. In fact, 80% of all the samples people coughed up were just saliva, and the machine found TB in them with 90% accuracy.
2. The "Gooey" Soup Wasn't Special: While the thick samples did have slightly more bacteria, the machine was so good at its job that it didn't matter. It could find the needle in the watery haystack just as easily as in the thick one.
3. Blood Didn't Matter: Even if the sample had a little blood in it (which some people worried might confuse the machine), the results were still accurate.

The Analogy: The Metal Detector

Think of the old way of testing like using a magnet. If you drop a magnet into a bucket of thick mud, it might pick up the iron nails (bacteria). But if you drop it into a bucket of clear water, the nails might sink to the bottom and the magnet misses them. So, you used to say, "Only test the mud!"

Xpert Ultra is like a super-sensitive metal detector that can beep even if the nail is buried deep in the water. It doesn't care if the water is muddy or clear; it finds the metal either way.

Why This Matters

This study tells us that we need to change the rules in hospitals, especially in places where TB is common.

• Stop Throwing Samples Away: Doctors and lab workers should stop rejecting "watery" spit. If a patient can only cough up clear saliva, that sample is still valuable and should be tested.
• Faster Cures: Throwing away samples causes delays. Patients have to come back, cough again, and wait longer for treatment. If we test everything, we catch the disease faster.
• Helping the Vulnerable: Some people, like those with HIV or young children, often can't produce thick, gooey sputum. Under the old rules, they were often told to come back later, delaying their care. Now, we know their saliva is enough to get a diagnosis.

The Bottom Line

The study concludes that the look of the spit doesn't matter anymore. Whether it's thick and yellow or clear and watery, the Xpert Ultra machine is smart enough to find the TB bacteria in both. It's time to stop judging a book by its cover (or a sample by its color) and start testing everything to save lives.

Technical Summary

1. Problem Statement

Historically, tuberculosis (TB) diagnostic protocols, rooted in the era of smear microscopy, have prioritized macroscopic sputum quality. Guidelines often classify thin, watery, or salivary sputum as "poor quality" and recommend rejecting these samples in favor of mucoid or purulent specimens, which were believed to correlate with higher bacillary loads.

However, the introduction of the Xpert MTB/RIF Ultra (Xpert Ultra) assay—a highly sensitive nucleic acid amplification test (NAAT) with a lower limit of detection than its predecessor—challenges this paradigm. Previous studies evaluating the impact of sputum quality on Xpert performance yielded mixed results, often limited by:

• Small sample sizes and single-country designs.
• Heterogeneous sputum grading systems.
• Reliance on the older, less sensitive Xpert MTB/RIF assay.
• Lack of standardized grading protocols.

The study aimed to determine whether macroscopic sputum appearance independently influences Xpert Ultra positivity and diagnostic accuracy, specifically to assess if current rejection criteria for "poor quality" (salivary) sputum are scientifically justified.

2. Methodology

Study Design:
A large-scale, multi-country, cross-sectional study conducted between June 2024 and March 2025 across seven high-burden TB countries: India, the Philippines, Vietnam, Nigeria, South Africa, Uganda, and Zambia. The study was part of the R2D2 TB Network and ADAPT studies.

Participants:

• Sample Size: 1,855 participants (after exclusions) with presumptive pulmonary TB.
• Inclusion Criteria: Age ≥12 years, cough ≥2 weeks, or specific risk factors (HIV, mining history, TB contact) with positive screening (CXR or CRP).
• Exclusion: Sputum induction required, recent TB treatment, or missing sputum grading data.

Procedures:

• Sputum Collection: Participants provided 2–3 expectorated sputum samples.
• Grading Protocol: Trained research staff graded the first sample using a standardized protocol with written definitions and photographic references. Grades included:
  • Salivary (thin/watery)
  • Mucoid (viscous/clear)
  • Purulent (thick/opaque/yellow-green)
  • Mixed categories (collapsed into the four main groups for analysis).
• Testing:
  • Index Test: Xpert MTB/RIF Ultra.
  • Reference Standard: Mycobacterial Culture (MRS) using liquid media for two specimens per participant.
• Statistical Analysis: Logistic regression was used to assess the association between sputum grade and Xpert positivity, adjusting for demographics and clinical variables. Sensitivity and specificity were calculated against the MRS.

3. Key Contributions

• Scale and Diversity: This is the largest and most geographically diverse evaluation of sputum quality and Xpert Ultra performance to date, covering sub-Saharan Africa, South Asia, and Southeast Asia.
• Standardization: Unlike previous studies, this research employed a unified, standardized grading protocol across all sites to minimize inter-observer variability.
• Robust Reference Standard: The use of a culture-based microbiological reference standard (MRS) from two specimens provides more accurate sensitivity/specificity estimates than studies relying on smear microscopy or composite clinical criteria.
• Assay Specificity: It specifically addresses the performance of the Xpert Ultra (second-generation), distinguishing it from findings related to the first-generation Xpert MTB/RIF.

4. Key Results

Participant Demographics:

• Median age: 39 years; 43% female; 19% living with HIV.
• Sputum Distribution: Salivary samples were the most common (82.6%), while purulent samples were rare (1.7%).

Xpert Ultra Positivity:

• Overall Positivity: 16.9% (313/1,855).
• By Grade:
  • Purulent: 31.3%
  • Mucopurulent: 21.7%
  • Mucoid: 19.8%
  • Salivary: 16.1%
• Statistical Association: In unadjusted analysis, purulent sputum appeared associated with higher positivity. However, after adjusting for country, age, sex, HIV status, and clinical symptoms, there was no significant independent association between any sputum grade and Xpert Ultra positivity.

Diagnostic Accuracy (vs. Culture):

• Overall Sensitivity: 89.6% (95% CI: 85.6–92.7).
• Overall Specificity: 98.7% (95% CI: 98.0–99.2).
• Sensitivity by Grade:
  • Purulent: 100% (n=10)
  • Mucoid: 91.4%
  • Mucopurulent: 87.0%
  • Salivary: 89.1% (95% CI: 84.6–92.7)
• Specificity: Remained consistently high (>98%) across all grades. While specificity was slightly lower for salivary samples (98.7%) compared to mucoid/purulent (100%), the absolute difference was minimal and likely not clinically meaningful.
• Blood-Stained Samples: Showed high sensitivity (93.8%) and specificity (100%), indicating no PCR inhibition issues.

5. Significance and Implications

Scientific Conclusion:
Macroscopic sputum quality is not an independent predictor of Xpert Ultra positivity or diagnostic accuracy. The Xpert Ultra assay is sufficiently sensitive to detect Mycobacterium tuberculosis complex (MTBC) in salivary specimens, which comprise the vast majority of samples in clinical practice.

Operational and Policy Impact:

• Guideline Revision: The study provides robust evidence to support revising national and international laboratory guidelines to accept all expectorated sputum samples regardless of macroscopic appearance.
• Equity and Access: Rejecting salivary sputum disproportionately excludes vulnerable groups (e.g., people living with HIV, children, early-stage disease patients) who may struggle to produce purulent sputum. Accepting all samples improves case detection in these populations.
• Workflow Efficiency: Eliminating subjective quality-based rejection criteria reduces diagnostic delays, decreases the need for repeat clinic visits, and simplifies laboratory workflows by removing a labor-intensive grading step.

Final Recommendation:
While patients should still be coached to produce high-quality specimens, salivary sputum is diagnostically useful for Xpert Ultra testing and should not be rejected. Removing sputum quality-based rejection criteria could significantly improve TB case detection and reduce diagnostic delays in high-burden settings globally.